Improved survival in patients with refractory glioblastoma that response to Irinotecan and Bevacizumab

  1. Hernandez-Jorge, A.
  2. Reyna, C.
  3. Espinos, J.
  4. de la Cruz, S.
  5. Santisteban, M.
  6. Fernandez-Hidalgo, O.
  7. Aramendia, J. M.
  8. Aristu, J. J.
  9. Garcia-Foncillas, J.
Journal:
EJC SUPPLEMENTS

ISSN: 1359-6349

Year of publication: 2009

Volume: 7

Issue: 2

Pages: 499-499

Congress: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Type: Conference paper

DOI: 10.1016/S1359-6349(09)71694-5 GOOGLE SCHOLAR

Sustainable development goals

Data source: WoS